American Journal of Cancer

Graduated Systemic Treatment of AIDS-Associated Kaposi Sarcoma: In the Era of Highly Active Antiretroviral Therapy
pp. 133-149(17)
Authors: Hengge, Ulrich R.; Tossing, Gudrun; Kouri, Vivian; Fruehauf , Stefan

Treatment of Anthracycline-Resistant Breast Cancer
pp. 151-162(12)
Authors: Friedman, Daniel T.; Sparano, Joseph A.

Refractory Chronic Lymphocytic Leukemia: Prognosis and Treatment Options
pp. 163-178(16)
Authors: Wierda, William G.; Keating, Michael J.; O'Brien, Susan

Primary Basal Cell Carcinoma: Current and Future Drug Treatment Options
pp. 179-186(8)
Authors: Zeitouni, Nathalie C.; Oseroff, Allan R.

Bevacizumab: In the Treatment of Colorectal Cancer
pp. 187-194(8)
Authors: Croom, Katherine F.; Foster, Rachel H.

Bevacizumab: A Viewpoint by Richard M. Goldberg
pp. 195-196(2)
Author: Goldberg, Richard M.

Bevacizumab: A Viewpoint by Al B. Benson III
pp. 195-196(2)
Author: Benson, Al B.

Leuprorelin: Subcutaneous Depot Formulation (Eligard®) for Advanced Prostate Cancer
pp. 197-201(5)
Authors: Evans, Hannah C.; Wagstaff, Antona J.

Subcutaneous Depot Leuprorelin: A Viewpoint by Navjeet Gandhok and Oliver Sartor
pp. 203-203(1)
Authors: Gandhok, Navjeet; Sartor, Oliver

Subcutaneous Depot Leuprorelin: A Viewpoint by Mark Rosenthal
pp. 203-203(1)
Author: Rosenthal, Mark